Organization · Venture Capital
Segulah Medical Acceleration
Segulah Medical Acceleration is a Stockholm-based investment organization focused on early-stage and growth-stage medical technology companies across Scandinavia and Western Europe. It aims to bridge the gap between research and commercialization in the medtech sector.
Overview
What Segulah Medical Acceleration does
What Segulah Medical Acceleration is
Segulah Medical Acceleration is a Stockholm-based investment organization focused on early-stage and growth-stage medical technology companies across Scandinavia and Western Europe. It aims to bridge the gap between research and commercialization in the medtech sector.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Structured capabilities
- Funder
- Last reviewed
- March 31, 2026
Official channels
Find Segulah Medical Acceleration elsewhere
Open the official website or a supported primary organization account.
Capability profile
Segulah Medical Acceleration as a funder
Investment thesis
Segulah Medical Acceleration focuses on bridging the gap between research and commercialization in the medical technology sector, investing in transformative products that improve patient outcomes.
Focus narrative
SMA invests in medical devices, diagnostics, life science tools, and health technology, primarily targeting growth and early commercialization stages. The organization emphasizes investments in products with global scaling potential, focusing on technologies that are at the finished product stage, particularly within the Nordic region and broader Western Europe.
Value beyond capital
SMA provides not only capital but also strategic commercialization support to its portfolio companies, leveraging its expertise in the medical technology sector to help them navigate the path from innovation to market success.
Terms and economics
- Typical check
- $2,000,000–$14,000,000
Focus and fit
- Stages
- Seed · Seed+ · Series A · Series A+ · Series B · Series B+ · Growth Equity
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 9
Portfolio context
SMA's portfolio includes notable companies such as: Senzime: Innovating in medical technology. Collective Minds Radiology: A platform for radiology collaboration. Navinci Diagnostics: Specializing in diagnostic technologies. Protembis: Innovating in medical devices. Allurion Technologies: Developing health technology solutions. SAGA Dx: Focused on diagnostics in oncology. Signifier Medical Technologies: Addressing sleep disorders with innovative technologies. Quanta Dialysis Technologies: Engaged in dialysis solutions. CytaCoat: Innovating in advanced wound care dressings.
Common questions
What to know about Segulah Medical Acceleration
Upseed classifies Segulah Medical Acceleration under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 31, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.